Bone decay and beyond: how can we approach it better.

bisphosphonate bone scaffolds dysbiosis gut microbiota metabolic disorders osseo-degeneration regenerative medicine

Journal

Journal of biological regulators and homeostatic agents
ISSN: 0393-974X
Titre abrégé: J Biol Regul Homeost Agents
Pays: Italy
ID NLM: 8809253

Informations de publication

Date de publication:
Historique:
entrez: 20 5 2020
pubmed: 20 5 2020
medline: 1 7 2020
Statut: ppublish

Résumé

Osseo-degeneration is a disorder related to several factors, that may lead to the disruption of several skeletal regions providing support, such as the femur head, the vertebrae and the alveolar bone. The functional condition can be restored by means of grafting procedures, using different materials: calcium powder, xenografts, ceramics and metals. Such procedures aim at reforming an adequate bone volume and strength, that is necessary to support loading forces. Bone regeneration requires that the basic biological principles of osteogenesis, osteoinduction, osteoconduction and biocompatibility are followed. The success of regenerative procedures may depend on the inner structural, mechanical and metabolic condition of the host's bone on which implants should be inserted, on the surgical technique, and on the biomaterial used. Among these, the aging process of the patient appears to be relevant. It can be associated with metabolic disease leading to systemic functional decay, which involves a gradual steady decline of hormonal, immune function and osteo-metabolic activity. The latter can affect the positive outcomes of bone reconstruction and implant therapy. This review will analyze the biological and physiological factors involved in the bone tissue break-down, such as the influences from gut microbiome unbalance and the consequent metabolic, endocrine, immune dysfunctions, the surgery procedures and the quality of the grafting material used. The decline of bone architecture and strength should be corrected by using an appropriate clinical regenerative approach, based on a bio-endocrine, metabolic and immunologic know-how. The final characteristics of the regenerated bone must be able to support the loading forces transmitted by the implants, independent of the body location, and should be individualized according to the different condition of each patient.

Identifiants

pubmed: 32425035
pii: 17

Substances chimiques

Bone Substitutes 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

143-154 DENTAL SUPPLEMENT

Informations de copyright

Copyright 2020 Biolife Sas. www.biolifesas.org.

Auteurs

C Gargiulo Isacco (C)

Department of Interdisciplinary Medicine (D.I.M.), the School of Medicine, University of Bari "Aldo Moro".
Pham Chau Trinh University of Medicine Hoi An City Vietnam.
Human Stem Cells Research Center HSC of Ho Chi Minh City Vietnam.

A Ballini (A)

Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari Aldo Moro, Italy.

G Paduanelli (G)

Department of Interdisciplinary Medicine (D.I.M.), the School of Medicine, University of Bari "Aldo Moro".

A D Inchingolo (AD)

Department of Interdisciplinary Medicine (D.I.M.), the School of Medicine, University of Bari "Aldo Moro".

K C D Nguyen (KCD)

Pham Chau Trinh University of Medicine Hoi An City Vietnam.

A M Inchingolo (AM)

Department of Interdisciplinary Medicine (D.I.M.), the School of Medicine, University of Bari "Aldo Moro".

V H Pham (VH)

Pham Chau Trinh University of Medicine Hoi An City Vietnam.

S K Aityan (SK)

Lincoln University, Oakland CA-USA.

M Schiffman (M)

Plastic Surgeon and Scientific Consultant, Los Angeles CA-USA.

T C Tran (TC)

Pham Chau Trinh University of Medicine Hoi An City Vietnam.

T D Huynh (TD)

Pham Chau Trinh University of Medicine Hoi An City Vietnam.

L Filgueira (L)

Faculty of Science and Medicine University of Fribourg, Fribourg-Switzerland.

A Scarano (A)

Department of Medical, Oral and Biotechnological Sciences, University of Chieti- Pescara, Chieti, Italy.

M Del Fabbro (M)

Department of Biomedical, Surgical and Dental Science, Università degli Studi di Milano, Milan, Italy.
IRCCS Orthopedic Institute Galeazzi, Milan, Italy.

C Mortellaro (C)

Saint Camillus International University of Health Sciences, Rome, Italy.

G Dipalma (G)

Department of Interdisciplinary Medicine (D.I.M.), the School of Medicine, University of Bari "Aldo Moro".

F Inchingolo (F)

Department of Interdisciplinary Medicine (D.I.M.), the School of Medicine, University of Bari "Aldo Moro".

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH